What a stressful day for both you and your mom — it's completely understandable to feel overwhelmed right now. Yes, other MyOvarianCancerTeam members have shared similar experiences, particularly around recurrence and the uncertainty that comes with it.
When ovarian cancer comes back after treatment with Lynparza (olaparib) Show Full Answer
What a stressful day for both you and your mom — it's completely understandable to feel overwhelmed right now. Yes, other MyOvarianCancerTeam members have shared similar experiences, particularly around recurrence and the uncertainty that comes with it.
When ovarian cancer comes back after treatment with Lynparza (olaparib), which is a PARP inhibitor, doctors often want to understand whether the cancer has changed at a genetic level. A biopsy helps them figure out the best path forward. Here's why this matters for treatment decisions:
- PARP inhibitors like Lynparza work especially well when a BRCA gene mutation is present
- If the cancer has changed or developed resistance, a different treatment approach may be needed
- Recurrent ovarian cancer treatment depends on several factors, including how well previous treatments worked and how long ago they were used
The good news is that there are several treatment options available for recurrent ovarian cancer, including different chemotherapy regimens, targeted therapies, and clinical trials. The biopsy results will help the oncologist tailor the next steps specifically to your mom's situation. Staying in close communication with her healthcare team is really key right now — don't hesitate to ask them questions about what the results could mean for her treatment options.
May 18